Article info
PDFInflammatory Bowel Disease
PWE-056 Single centre experience of vedolizumab in the management of moderate to severe ulcerative colitis and crohn’s disease
Citation
PWE-056 Single centre experience of vedolizumab in the management of moderate to severe ulcerative colitis and crohn’s disease
Publication history
- First published June 17, 2017.
Online issue publication
November 20, 2017
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2017, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions